Boehringer Ingelheim Venture Fund Parent: Boehringer Ingelheim

The strategic venture fund of the Boehringer Ingelheim Corporation invests around the world in pioneering science that offers the potential to provide a significant benefit for patients. The firm takes an active role with its portfolio companies, delivering significant added value through its own extensive drug discovery, scientific and managerial expertise and access to selected relevant experts and knowledge. In addition to its headquarters in Germany, Boehringer Ingelheim Venture Fund also has offices in Beijing, China and Cambridge, Massachusetts.